Anna Owings
Gastroenterology · Nashville, TNNPI 1588151807
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.7% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 28.7% of the total. 2025 is the largest year on record at $2,001, more than ten times the $13 reported in 2020. That places this record below the midpoint for gastroenterology clinicians in TN, where the typical reported total is $2,975.
Across 132 payments — averaging $26.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$989
- Johnson & Johnson$737
- Takeda Pharmaceuticals U.S.A., Inc.$337
- Ardelyx, Inc.$164
- Medtronic$150
- Madrigal Pharmaceuticals$130
- plus $938 from 15 others
What the payments were for
- Food & beverage$3,26195%
- Education$1835%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $989 |
| Johnson & Johnson | 23 | $737 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $337 |
| Ardelyx, Inc. | 8 | $164 |
| Medtronic | 1 | $150 |
| Madrigal Pharmaceuticals | 5 | $130 |
| Janssen Scientific Affairs, LLC | 1 | $130 |
| Olympus America Inc. | 2 | $108 |
| Pfizer | 4 | $94 |
| Mallinckrodt Hospital Products Inc. | 1 | $88 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $78 |
| Gilead | 4 | $73 |
| Sanofi | 3 | $70 |
| Intercept Pharmaceuticals, Inc. | 4 | $70 |
| Celltrion USA Inc. | 3 | $44 |
| Ipsen Biopharmaceuticals, Inc | 2 | $36 |
| QOL Medical, LLC | 1 | $21 |
| Bristol Myers Squibb | 1 | $19 |
| Merck | 1 | $14 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,444 in reported general payments places this provider in the 50th percentile of 336 gastroenterology providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 14 | $150 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Nashville
- David SchwartzNashville$1.3M
- Dawn Borromeo BeaulieuNashville$421K
- Sara HorstNashville$246K
- Rishi NaikNashville$136K
- Dhyanesh PatelNashville$98K
- Michael VaeziNashville$78K
- Baldeep PablaNashville$55K
- Robin DalalNashville$27K
- Howard MertzNashville$26K
- Dawn AdamsNashville$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.